Neurologist - Brain Specialist: Gabriel Yiin | National Neuroscience Institute
Skip Ribbon Commands
Skip to main content
Menu
Dr Gabriel Shih Chung Yiin

Dr Yiin Gabriel Shih Chung

BMBS, MRCP(UK), DPHIL (OXON), FRCP (London)

Senior Consultant

National Neuroscience Institute

Specialty: Neurology

Clinical Interest: Stroke

Conditions Treated by this Doctor:
General Neurology, Stroke.

Clinical Appointments

  • Senior Consultant Department of Neurology National Neuroscience InstituteNational Neuroscience Institute
  • Senior Consultant Neurology Singapore General HospitalSingapore General Hospital

Profile

Dr Gabriel Yiin is a Senior Consultant at the Department of Neurology, National Neuroscience Institute (NNI@SGH). Dr Yiin received his medical degree from the University of Nottingham in 2002 and MRCP (UK) in 2005. He received his Neurology specialist training in Oxford and Newcastle (UK) from 2006 to 2014.

He had also completed a DPhil at the University of Oxford in 2014. His research focused on systematic reviews of stroke incidence studies, clinical epidemiology of atrial fibrillation-related vascular events, and methods to improve secondary prevention using prolonged cardiac monitoring and biomarkers.

When he was working as a Consultant Neurologist at Great Western Hospital (UK), he was part of the Thrombectomy Innovation and Transformation Network to implement the Brainomix AI software as a decision aided tool in district general hospitals to facilitate transfer of eligible stroke patients to tertiary unit for mechanical thrombectomy.

Education

  • Fellow of Royal College of Physicians (London), 2020
  • DPhil in Clinical Neurology, University of Oxford, 2014
  • Certificate of Completion of Specialist Training (Neurology), 2014
  • Member of the Royal College of Physicians (MRCP UK), 2005
  • BMBS, 2002
  • B.Med.Sci honors’ degree (First Class), 2000

Professional Appointments and Committee Memberships

  • Senior Consultant, Department of Neurology, National Neuroscience Institute (NNI@SGH)​

Awards

Research Interests

Publications

  • ​Bengeri S, Mark LS, Osomo OA, Kuker K, Yiin GSC. Segmental microbleeds: a radiological sign for cranial arteriovenous fistula. Clinical medicine 2023;23(5):512-514
  • Keh R, Scanlon S, Datta-Nemdharry P, Donegan K, Cavanagh S, Foster M, et al. COVID-19 vaccination and Guillain-Barre syndrome: analyses using the National Immunoglobulin Database. Brain 2023;146(2):739-748
  • Marren S, Beale A, Yiin GSC. Hyperosmolar hyperglycaemic state as a stroke cause or stroke mimic: an illustrative case and review of literature. Clinical Medicine 2022;22(1):83-86
  • Gurowich L, Maxwell A, Rice A, Yiin GSC. Post-thymectomy myasthenia gravis – a case report and systematic review of literature. BMJ case reports 2021;14(12):e246005
  • Haire E, Whitehouse E, Baker I, Beale A, Gonzalez L, Khan A, Yiin GSC. Ischaemic stroke caused by Group B Streptococcus associated meningoencephalitis in young immunocompetent adults – a case series and systematic review of literature. Acute Medicine 2021;20(4):290-293
  • Helliwell H, Desai A, McCole M, Beale A, Chandrasekeran B, Yiin GSC. The importance of early completion of cardiac investigations for ischaemic stroke – an illustrative case with cardiac fibroelastoma and a systematic review of outcomes after reperfusion therapies. Clinical Medicine 2020;20(6):597-599
  • Walters B, Lazic D, Ahmed A, Yiin GS. Lessons of the month 4: Giant cell arteritis with normal inflammatory markers and isolated oculomotor nerve palsy: Clinical Medicine 2020;20(2):224-226
  • Boulanger M, Li L, Lyons S, Lovett N, Kubiak M, Silver L, Touze E, Rothwell PM. Effect of coexisting vascular disease on long term risk of recurrent events after TIA or stroke. Neurology 2019;93(7):e695-e707
  • Yiin GSC, Li L, Bejot Y, Rothwell PM. Time trends in AF-related stroke and premorbid anticoagulation: population-based study and systematic review. Stroke 2019;50:21-27
  • Yiin GSC, Howard DPJ, Paul NLM, Li L, Mehta Z, Rothwell PM. Recent time trends in incidence, outcome, and pre-morbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study. Journal of Neurosurgery, Neurology and Psychiatry 2017;88(1):12-18
  • Li L, Yiin GS, Geraghty OC, Schulz UG, Kuker W, Mehta Z, Rothwell PM. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet neurol. 2015;14(9):903-13
  • Yiin GSC, Howard DPJ, Paul NLM, Linxin Li, Luengo-Fernandez R, Bull LM, Welch SJV, Gutnikov SA, Mehta Z, Rothwell PM. Age-specific incidence, outcome, cost and projected future burden of atrial fibrillation-related vascular events: a population-based study. Circulation 2014;130(15):1236-44
  • Meschia JF, Arnett DK, Brown RD, Benavente OR, Cole JW, de Bakker PI, et al. Stroke Genetics Network (SiGN) Study: design and rationale for a genome-wide association study of ischaemic stroke subtypes. Stroke 2013; 44(10):2694-702
  • Luengo-Fernandez R, Yiin GSC, Gray AM, Rothwell PM. Population-based study of acute- and long-term care costs after stroke in patients with AF. Int J Stroke 2013; 8(5):308-14

Research Trials